Editorial: Second Line Treatment of Non-Small Cell Lung Cancer: Clinical, Pathological and Molecular Aspects of Novel Promising Drugs

Editorial: Second Line Treatment of Non-Small Cell Lung Cancer: Clinical, Pathological and Molecular Aspects of Novel Promising Drugs

Bibliographic Details
Main Authors: Umberto Malapelle, Pierlorenzo Pallante
Format: Article
Language:English
Published: Frontiers Media S.A. 2017-05-01
Series:Frontiers in Medicine
Subjects:
NSCLC
liquid biopsy diagnostics
precision medicine
molecular markers
immunotherapy
antiangiogenic therapy
Online Access:http://journal.frontiersin.org/article/10.3389/fmed.2017.00063/full
id doaj-eb35d4ac55d640a88fca9c894d6915a4
record_format Article
spelling doaj-eb35d4ac55d640a88fca9c894d6915a42020-11-24T20:47:14ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2017-05-01410.3389/fmed.2017.00063273946Editorial: Second Line Treatment of Non-Small Cell Lung Cancer: Clinical, Pathological and Molecular Aspects of Novel Promising DrugsUmberto Malapelle0Pierlorenzo Pallante1Department of Public Health, University of Naples Federico II, Naples, ItalyInstitute of Experimental Endocrinology and Oncology (IEOS) “G. Salvatore”, National Research Council (CNR), Naples, Italyhttp://journal.frontiersin.org/article/10.3389/fmed.2017.00063/fullNSCLCliquid biopsy diagnosticsprecision medicinemolecular markersimmunotherapyantiangiogenic therapy
collection DOAJ
language English
format Article
sources DOAJ
author Umberto Malapelle
Pierlorenzo Pallante
spellingShingle Umberto Malapelle
Pierlorenzo Pallante
Editorial: Second Line Treatment of Non-Small Cell Lung Cancer: Clinical, Pathological and Molecular Aspects of Novel Promising Drugs
Frontiers in Medicine
NSCLC
liquid biopsy diagnostics
precision medicine
molecular markers
immunotherapy
antiangiogenic therapy
author_facet Umberto Malapelle
Pierlorenzo Pallante
author_sort Umberto Malapelle
title Editorial: Second Line Treatment of Non-Small Cell Lung Cancer: Clinical, Pathological and Molecular Aspects of Novel Promising Drugs
title_short Editorial: Second Line Treatment of Non-Small Cell Lung Cancer: Clinical, Pathological and Molecular Aspects of Novel Promising Drugs
title_full Editorial: Second Line Treatment of Non-Small Cell Lung Cancer: Clinical, Pathological and Molecular Aspects of Novel Promising Drugs
title_fullStr Editorial: Second Line Treatment of Non-Small Cell Lung Cancer: Clinical, Pathological and Molecular Aspects of Novel Promising Drugs
title_full_unstemmed Editorial: Second Line Treatment of Non-Small Cell Lung Cancer: Clinical, Pathological and Molecular Aspects of Novel Promising Drugs
title_sort editorial: second line treatment of non-small cell lung cancer: clinical, pathological and molecular aspects of novel promising drugs
publisher Frontiers Media S.A.
series Frontiers in Medicine
issn 2296-858X
publishDate 2017-05-01
topic NSCLC
liquid biopsy diagnostics
precision medicine
molecular markers
immunotherapy
antiangiogenic therapy
url http://journal.frontiersin.org/article/10.3389/fmed.2017.00063/full
work_keys_str_mv AT umbertomalapelle editorialsecondlinetreatmentofnonsmallcelllungcancerclinicalpathologicalandmolecularaspectsofnovelpromisingdrugs
AT pierlorenzopallante editorialsecondlinetreatmentofnonsmallcelllungcancerclinicalpathologicalandmolecularaspectsofnovelpromisingdrugs
_version_ 1716810593526087680

Similar Items